Vertex Pharmaceuticals Incorporated (VRTX)

Nasdaq · Health Care · Large-Cap Pharmaceuticals

Key financials

Revenue
$12.6 billion
Operating margin
38.0%
Net margin
35.0%
Free cash flow
$3.8 billion

12 months to · Definitions

Last close $558.88 on Fri Oct 30 · Chart: daily closes, adjusted for splits

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers, develops, and commercializes prescription medicines, generating revenue primarily from product sales of its approved therapies (notably in cystic fibrosis (CF)) and…

Headquarters
BOSTON, MA, United States
Website
not available

VRTX stories

RSS for VRTX